ROSIGLITAZONE IS EFFECTIVE AND SAFE IN THE TREATMENT OF POSTTRANSPLANT DIABETES MELLITUS AFTER RENAL TRANSPLANTATION

Authors :: T Philipp
O Janssen
T Ngo Van
Daniel Patschan
Klaus Mann
Andreas Kribben
F Pietruck
Oliver Witzke
Source :: Transplantation. 78:300
Publication Year :: 2004
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2004.

Subjects :: Transplantation
medicine.medical_specialty
business.industry
medicine
Urology
Posttransplant diabetes mellitus
Rosiglitazone
business
medicine.drug

Full Text Access

Tools